Leadership Overview
Myriad Genetics has 5 executives leading key functions including financial strategy, legal compliance, human resources, women's health operations, and corporate leadership.
Focused on advancing precision medicine, Myriad Genetics delivers critical genomic insights to improve patient outcomes through innovative diagnostic testing and personalized treatment guidance across diverse medical specialties.
Focused on advancing precision medicine, Myriad Genetics delivers critical genomic insights to improve patient outcomes through innovative diagnostic testing and personalized treatment guidance across diverse medical specialties.
Leadership Roles at Myriad Genetics
Benjamin Wheeler - Chief Financial Officer
Benjamin Wheeler, the Chief Financial Officer at Myriad Genetics, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust investment in molecular diagnostic research and development. This leadership role involves managing investor relations and maintaining rigorous internal controls to support long-term growth. By optimizing the capital structure, Benjamin Wheeler directly impacts the ability of the company to scale precision medicine offerings across North American markets. Ultimately, Wheeler secures the financial stability required to sustain the development of hereditary cancer and oncology testing portfolios. Through disciplined oversight of budgetary resources, the Chief Financial Officer aligns fiscal performance with the broader mission of delivering actionable genomic data to healthcare providers and patients globally, ensuring the company remains a leader in the competitive molecular diagnostics landscape.
Melissa Gonzales - President, Women's Health, Myriad Genetics
Melissa Gonzales, the President, Women's Health, Myriad Genetics at Myriad Genetics, directs the commercial strategy and product expansion for the prenatal and reproductive health divisions. Overseeing the development of advanced genetic screening tools, the President, Women's Health, Myriad Genetics ensures that clinical providers receive accurate data for informed patient care. This leadership role involves managing market penetration strategies for hereditary cancer risk panels and reproductive health tests. By optimizing the delivery of these essential diagnostic services, Melissa Gonzales directly impacts the health outcomes of women across diverse patient populations. Ultimately, Gonzales expands the reach of the company's portfolio to address critical needs in prenatal and reproductive medicine. Through rigorous focus on clinical utility and market growth, the President, Women's Health, Myriad Genetics strengthens the company's position as a trusted partner in women's healthcare, driving innovation in diagnostic testing and patient support services.
Mark Verratti - President
Mark Verratti, the President at Myriad Genetics, directs the overarching operational execution and strategic vision for the entire molecular diagnostics portfolio. Overseeing the integration of research, development, and commercialization efforts, the President ensures that the company maintains its leadership in precision medicine. This leadership role involves coordinating with the Board and executive team to drive growth across oncology, urology, and mental health testing segments. By aligning corporate objectives with market needs, Mark Verratti directly impacts the scalability of the company's diagnostic platforms. Ultimately, Verratti fosters a culture of innovation that accelerates the delivery of genomic tests to clinical settings. Through comprehensive management of business operations, the President supports the company's mission to provide actionable insights that guide treatment decisions, ensuring that the organization remains at the forefront of the rapidly evolving field of genetic and genomic testing.
Amy Sarola - Legal & Compliance Operations Chief of Staff
Amy Sarola, the Legal & Compliance Operations Chief of Staff at Myriad Genetics, directs the integration of regulatory standards across all diagnostic product lines. Overseeing the alignment of internal policies with evolving healthcare laws, the Legal & Compliance Operations Chief of Staff mitigates operational risk while facilitating rapid innovation in genomic testing. This leadership role involves coordinating cross-functional teams to ensure adherence to complex medical regulations in the United States and international markets. By streamlining compliance workflows, Amy Sarola directly impacts the efficiency of the product development lifecycle. Ultimately, Sarola protects the integrity of the company's diagnostic data and clinical research initiatives. Through proactive management of legal frameworks, the Legal & Compliance Operations Chief of Staff supports the delivery of reliable, high-quality genetic insights that guide treatment decisions for patients facing hereditary cancer and other complex health conditions.
Shereen Solaiman - Chief People Officer
Shereen Solaiman, the Chief People Officer at Myriad Genetics, directs the talent acquisition and organizational development strategies necessary to support a high-growth precision medicine firm. Overseeing the cultivation of a specialized workforce, the Chief People Officer ensures the company attracts top-tier scientific and clinical talent. This leadership role involves designing performance management systems that foster innovation in oncology and reproductive health diagnostics. By championing a culture of excellence, Shereen Solaiman directly impacts the operational capacity of the organization to meet increasing demand for genomic testing. Ultimately, Solaiman drives employee engagement and professional growth initiatives that align with the company's mission to improve patient care. Through strategic workforce planning, the Chief People Officer maintains the human capital required to sustain the company's competitive advantage in the molecular diagnostics industry, ensuring that teams remain focused on delivering life-changing diagnostic solutions to patients.
Explore Leadership Teams in Business Services
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership JP
Founded in 2012, WCG measurably improves the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the development of new treatments and therapies for patients. The company is headquartered in Princeton, New Jersey.
Company Leadership PM
AC
Embrapa (Brazilian Agricultural Research Corporation) is a Brazilian public research institution headquartered in Brasilia, Brazil. Founded in 1973 and linked to the Ministry of Agriculture, Embrapa conducts agricultural research and development to improve productivity, sustainability, and competitiveness of Brazilian agriculture. The organization operates a network of research centers across Brazil.
Company Leadership SM
RC
FO
Radiance Technologies is an employee-owned prime contractor that delivers innovative solutions to address complex challenges faced by its customers. Operating in environments where adversaries are continually evolving, the company provides technological advantages and operational superiority to support national security and mission success.
Company Leadership
TS
Frequently Asked Questions Regarding Myriad Genetics Top Executives and Leadership Team
Unlock more people and company data
